Flohr C, Irvine AD, Cork MJ, Simpson EL, et al. Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6-11 years with severe atopic dermatitis. Br J Dermatol 2023 Apr 30:ljad124. doi: 10.1093.
PMID: 37120724